Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
Completed · Phase 2
Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders
In brief
The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.
Key facts
- Study ID
- NCT00015223
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 0
- Starts
- 1997-06-01
- Expected to finish
- 1999-08-01
- Last updated by the study team
- 2017-01-16
Who can join
Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the past 30 days of screening.
You may not qualify if…
- Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or benzos. History of seizures.
Where it is running
- Cincinnati MDRU — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.